It’s been almost a quarter century since the first drug was approved for stroke. But what’s even more striking is that only a single drug remains approved today. In a publication appearing this month in the journal Translational Stroke Research, the TNRR Laboratory and Aruna Bio, funded by the National Institutes of Health, present brain-imaging data for a new stroke treatment that supported full recovery in swine, modeled with the same pattern of neurodegeneration as seen in humans with severe stroke. Read the full article news.uga.edu.

Posted in: